The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
暂无分享,去创建一个
J. Schwarz | R. Lustig | J. Lim | M. Mietus-Snyder | A. Valente | J. Lim | J. Lim | Michele Mietus-Snyder
[1] B. Lin,et al. Sweetener Consumption in the United States: Distribution by Demographic and Product Characteristics , 2012 .
[2] F. van der Leij,et al. Regulatory enzymes of mitochondrial β‐oxidation as targets for treatment of the metabolic syndrome , 2010, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[3] I. Rusyn,et al. Mechanism for prevention of alcohol-induced liver injury by dietary methyl donors. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[4] L. Orci,et al. Lipid homeostasis, lipotoxicity and the metabolic syndrome. , 2010, Biochimica et biophysica acta.
[5] J. Schold,et al. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response , 2010, International Journal of Obesity.
[6] S. Haffner,et al. Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population , 2009, Diabetic medicine : a journal of the British Diabetic Association.
[7] E. Brunt. Histopathology of non-alcoholic fatty liver disease. , 2009, Clinics in liver disease.
[8] A. Diehl,et al. Apoptosis and cytokines in non-alcoholic steatohepatitis. , 2009, Clinics in liver disease.
[9] A. Sanyal,et al. Endoplasmic reticulum stress and the unfolded protein response. , 2009, Clinics in liver disease.
[10] F. Al-Mohanna,et al. Diabetes of the Liver: The Link Between Nonalcoholic Fatty Liver Disease and HFCS‐55 , 2009, Obesity.
[11] A. Abid,et al. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. , 2009, Journal of hepatology.
[12] G. Watts,et al. Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy. , 2009, The Journal of clinical endocrinology and metabolism.
[13] B. Fielding,et al. Liver fat and lipid oxidation in humans , 2009, Liver international (Print).
[14] Scott M Turner,et al. Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis[S] , 2009, Journal of Lipid Research.
[15] K. Long,et al. Impact of micronutrient deficiencies on obesity. , 2009, Nutrition reviews.
[16] João Wosniak,et al. Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. , 2009, Antioxidants & redox signaling.
[17] Judith Wylie-Rosett,et al. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. , 2009, Circulation.
[18] B. S. Mohammed,et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity , 2009, Proceedings of the National Academy of Sciences.
[19] F. Marra,et al. Adipokines in liver diseases , 2009, Hepatology.
[20] I. Bergheim,et al. Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease. , 2009, The Journal of nutritional biochemistry.
[21] F. Schick,et al. Dissociation Between Fatty Liver and Insulin Resistance in Humans Carrying a Variant of the Patatin-Like Phospholipase 3 Gene , 2009, Diabetes.
[22] A. Feldstein,et al. Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal , 2009, Expert review of gastroenterology & hepatology.
[23] R. Rao. Endotoxemia and gut barrier dysfunction in alcoholic liver disease , 2009, Hepatology.
[24] R. Auten,et al. Oxygen Toxicity and Reactive Oxygen Species: The Devil Is in the Details , 2009, Pediatric Research.
[25] Linda Wasserbach York,et al. Nonalcoholic fatty liver disease and low-carbohydrate diets. , 2009, Annual review of nutrition.
[26] K. Adeli,et al. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[27] Hyon K. Choi,et al. Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents. , 2009, The Journal of pediatrics.
[28] J. Bantle,et al. Dietary fructose and metabolic syndrome and diabetes. , 2009, The Journal of nutrition.
[29] R. Kreis,et al. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. , 2009, The American journal of clinical nutrition.
[30] R. Townsend,et al. Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses. , 2009, The Journal of clinical endocrinology and metabolism.
[31] Wei Zhang,et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. , 2009, The Journal of clinical investigation.
[32] M. Grosovski,et al. Olive oil consumption and non-alcoholic fatty liver disease. , 2009, World journal of gastroenterology.
[33] W. R. Bruce,et al. Fructose and carbonyl metabolites as endogenous toxins. , 2009, Chemico-biological interactions.
[34] G. Shulman,et al. The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. , 2009, Cell metabolism.
[35] Jihyun Song,et al. Coupling mitochondrial dysfunction to endoplasmic reticulum stress response: a molecular mechanism leading to hepatic insulin resistance. , 2009, Cellular signalling.
[36] D. Kershenobich,et al. Acetaldehyde-induced mitochondrial dysfunction sensitizes hepatocytes to oxidative damage , 2009, Cell Biology and Toxicology.
[37] Pedro Rada,et al. Evidence for sugar addiction: Behavioral and neurochemical effects of intermittent, excessive sugar intake , 2008, Neuroscience & Biobehavioral Reviews.
[38] J. Montani,et al. Sugary drinks in the pathogenesis of obesity and cardiovascular diseases , 2008, International Journal of Obesity.
[39] M. Lane,et al. Differential effects of central fructose and glucose on hypothalamic malonyl–CoA and food intake , 2008, Proceedings of the National Academy of Sciences.
[40] Jeanne M Clark,et al. The epidemiology of nonalcoholic fatty liver disease: a global perspective. , 2008, Seminars in liver disease.
[41] M. Yeh,et al. Animal models of NASH: Getting both pathology and metabolic context right , 2008, Journal of gastroenterology and hepatology.
[42] B. Neuschwander‐Tetri,et al. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[43] A. Feldstein,et al. Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive , 2008, Seminars in liver disease.
[44] C. Erlanson‐Albertsson,et al. Effects of sucrose, glucose and fructose on peripheral and central appetite signals , 2008, Regulatory Peptides.
[45] W. Nseir,et al. Soft drink consumption linked with fatty liver in the absence of traditional risk factors. , 2008, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[46] Alexander Pertsemlidis,et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.
[47] M. Pagliassotti,et al. The role of fatty acids in the development and progression of nonalcoholic fatty liver disease. , 2008, The Journal of nutritional biochemistry.
[48] Richard J. Johnson,et al. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. , 2008, JAMA.
[49] S. Bischoff,et al. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. , 2008, The Journal of nutrition.
[50] B. S. Mohammed,et al. Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents. , 2008, The American journal of clinical nutrition.
[51] R. Ferraris,et al. Regulation of the fructose transporter GLUT5 in health and disease. , 2008, American journal of physiology. Endocrinology and metabolism.
[52] M. Stampfer,et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. , 2008, The New England journal of medicine.
[53] J. Kimmons,et al. Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. , 2008, Medscape journal of medicine.
[54] R. DePinho,et al. Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. , 2008, Cell metabolism.
[55] M. Bortolotti,et al. Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease , 2008, Current opinion in clinical nutrition and metabolic care.
[56] D. Crabb,et al. Alcohol and lipid metabolism. , 2008, American journal of physiology. Endocrinology and metabolism.
[57] R. Krauss,et al. Polymorphisms in the peroxisome proliferator activated receptor alpha gene are associated with levels of apolipoprotein CIII and triglyceride in African-Americans but not Caucasians. , 2008, Atherosclerosis.
[58] S. McCall,et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. , 2008, Journal of hepatology.
[59] Manabu T. Nakamura,et al. Dietary fructose induces a wide range of genes with distinct shift in carbohydrate and lipid metabolism in fed and fasted rat liver. , 2008, Biochimica et biophysica acta.
[60] A. Chakraborti,et al. Fructose-induced structural and functional modifications of hemoglobin: implication for oxidative stress in diabetes mellitus. , 2008, Biochimica et biophysica acta.
[61] G. Musso,et al. Should Nonalcoholic Fatty Liver Disease Be Included in the Definition of Metabolic Syndrome? A Cross-Sectional Comparison With Adult Treatment Panel III Criteria in Nonobese Nondiabetic Subjects , 2008, Diabetes Care.
[62] Javier García-Villafranca,et al. Ethanol consumption impairs regulation of fatty acid metabolism by decreasing the activity of AMP-activated protein kinase in rat liver. , 2008, Biochimie.
[63] N. Hamajima,et al. Metabolic syndrome defined by new criteria in Japanese is associated with increased liver enzymes and C-reactive protein. , 2008, Nagoya journal of medical science.
[64] S. Msika,et al. High Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Morbid Obesity: A Contributor to Severe Hepatic Steatosis , 2008, Obesity surgery.
[65] M. Rigoulet,et al. Mitochondrial adaptations to steatohepatitis induced by a methionine- and choline-deficient diet. , 2008, American journal of physiology. Endocrinology and metabolism.
[66] G. Shulman,et al. Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance , 2007, Proceedings of the National Academy of Sciences.
[67] G. Bray. How bad is fructose? , 2007, The American journal of clinical nutrition.
[68] Takahiko Nakagawa,et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. , 2007, The American journal of clinical nutrition.
[69] Bohan Wang,et al. Hypoxia increases expression of selective facilitative glucose transporters (GLUT) and 2-deoxy-d-glucose uptake in human adipocytes , 2007, Biochemical and biophysical research communications.
[70] K. Pietiläinen,et al. Liver fat in the metabolic syndrome. , 2007, The Journal of clinical endocrinology and metabolism.
[71] J. Plutzky,et al. PPARα in atherosclerosis and inflammation , 2007 .
[72] J. German,et al. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. , 2007, The American journal of clinical nutrition.
[73] Hyon K. Choi,et al. Intake of Added Sugar and Sugar-Sweetened Drink and Serum Uric Acid Concentration in US Men and Women , 2007, Hypertension.
[74] Ralph B. D'Agostino,et al. Soft Drink Consumption and Risk of Developing Cardiometabolic Risk Factors and the Metabolic Syndrome in Middle-Aged Adults in the Community , 2007, Circulation.
[75] Jian-Gao Fan,et al. Effects of nonalcoholic fatty liver disease on the development of metabolic disorders , 2007, Journal of gastroenterology and hepatology.
[76] E. Roberts,et al. Pediatric nonalcoholic fatty liver disease (NAFLD): a "growing" problem? , 2007, Journal of hepatology.
[77] K. Adeli,et al. Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms. , 2007, Nutrition reviews.
[78] D. Pessayre. Role of mitochondria in non‐alcoholic fatty liver disease , 2007, Journal of gastroenterology and hepatology.
[79] G. Musso,et al. Polymorphism in microsomal triglyceride transfer protein: A link between liver disease and atherogenic postprandial lipid profile in NASH? , 2007, Hepatology.
[80] C. McClain,et al. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition. , 2007, The Journal of nutritional biochemistry.
[81] M. Vázquez-Carrera,et al. Impairment of hepatic Stat‐3 activation and reduction of PPARα activity in fructose‐fed rats , 2007, Hepatology.
[82] C. Romestaing,et al. Long term highly saturated fat diet does not induce NASH in Wistar rats , 2007, Nutrition & metabolism.
[83] D. Jacobs,et al. Trends in diet quality for coronary heart disease prevention between 1980-1982 and 2000-2002: The Minnesota Heart Survey. , 2007, Journal of the American Dietetic Association.
[84] Allison Gruner Gandhi,et al. The Devil Is in the Details , 2007, Evaluation review.
[85] B. Mackey,et al. Dietary trans 10, cis 12-conjugated linoleic acid reduces the expression of fatty acid oxidation and drug detoxification enzymes in mouse liver , 2007, British Journal of Nutrition.
[86] J. Plutzky,et al. PPARalpha in atherosclerosis and inflammation. , 2007, Biochimica et biophysica acta.
[87] M. Pagliassotti,et al. Fructose-mediated stress signaling in the liver: implications for hepatic insulin resistance. , 2007, The Journal of nutritional biochemistry.
[88] Y. Hiasa,et al. Dietary habits and nutrient intake in non-alcoholic steatohepatitis. , 2007, Nutrition.
[89] K. Petersen,et al. Molecular Mechanisms of Insulin Resistance in Humans and Their Potential Links With Mitochondrial Dysfunction , 2006, Diabetes.
[90] H. Stratton,et al. Fruit Juice Intake Predicts Increased Adiposity Gain in Children From Low-Income Families: Weight Status-by-Environment Interaction , 2006, Pediatrics.
[91] X. Papademetris,et al. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. , 2006, The Journal of clinical endocrinology and metabolism.
[92] B. Eskenazi,et al. Soda Consumption and Overweight Status of 2‐Year‐Old Mexican‐American Children in California , 2006, Obesity.
[93] C. Sirlin,et al. Pediatric Nonalcoholic Fatty Liver Disease: A Critical Appraisal of Current Data and Implications for Future Research , 2006, Journal of pediatric gastroenterology and nutrition.
[94] Jeffrey B. Schwimmer,et al. Prevalence of Fatty Liver in Children and Adolescents , 2006, Pediatrics.
[95] G. Svegliati-Baroni,et al. A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. , 2006, The American journal of pathology.
[96] J. Girard,et al. Liver-Specific Inhibition of ChREBP Improves Hepatic Steatosis and Insulin Resistance in ob/ob Mice , 2006, Diabetes.
[97] R. Lustig. Childhood obesity: behavioral aberration or biochemical drive? Reinterpreting the First Law of Thermodynamics , 2006, Nature Clinical Practice Endocrinology &Metabolism.
[98] M. Karin,et al. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[99] G. Radetti,et al. Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging. , 2006, Acta paediatrica.
[100] L. Tappy,et al. Metabolic effects of fructose , 2006, Current opinion in clinical nutrition and metabolic care.
[101] Michael Roden,et al. Mechanisms of Disease: hepatic steatosis in type 2 diabetes—pathogenesis and clinical relevance , 2006, Nature Clinical Practice Endocrinology &Metabolism.
[102] G. Lewis,et al. Hyperinsulinemia Is Associated With Increased Production Rate of Intestinal Apolipoprotein B-48–Containing Lipoproteins in Humans , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[103] G. Shulman,et al. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. , 2006, The Journal of clinical investigation.
[104] R. Goldin,et al. Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research , 2006, International journal of experimental pathology.
[105] P. Scifo,et al. Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes , 2005, Diabetologia.
[106] Y. Iwamoto,et al. Prevalence of non‐alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[107] M. Pagliassotti,et al. Fructose selectively modulates c-jun N-terminal kinase activity and insulin signaling in rat primary hepatocytes. , 2005, The Journal of nutrition.
[108] C. Koebnick,et al. Consuming fructose-sweetened beverages increases body adiposity in mice. , 2005, Obesity research.
[109] D. Faeh,et al. Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. , 2005, Diabetes.
[110] J. Jessurun,et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.
[111] A. Häkkinen,et al. Dietary fat content modifies liver fat in overweight nondiabetic subjects. , 2005, The Journal of clinical endocrinology and metabolism.
[112] P. Havel. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. , 2005, Nutrition reviews.
[113] G. Link,et al. Fructose-Induced Fatty Liver Disease: Hepatic Effects of Blood Pressure and Plasma Triglyceride Reduction , 2005, Hypertension.
[114] D. Kleiner,et al. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy , 2005, Hepatology.
[115] D. Cook,et al. Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes. , 2005, American journal of physiology. Endocrinology and metabolism.
[116] U. Edvardsson,et al. Activation of Peroxisome Proliferator-activated Receptor α Increases the Expression and Activity of Microsomal Triglyceride Transfer Protein in the Liver* , 2005, Journal of Biological Chemistry.
[117] T. Yanagita,et al. Dietary conjugated linoleic acid alleviates nonalcoholic fatty liver disease in Zucker (fa/fa) rats. , 2005, The Journal of nutrition.
[118] C. Schalkwijk,et al. Fructose‐mediated non‐enzymatic glycation: sweet coupling or bad modification , 2004, Diabetes/metabolism research and reviews.
[119] D. Crabb,et al. Molecular mechanisms of alcoholic fatty liver: role of sterol regulatory element-binding proteins. , 2004, Alcohol.
[120] P. Berk,et al. Lipid metabolism in hepatic steatosis. , 2004, Clinics in liver disease.
[121] C. Lieber,et al. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. , 2004, Alcohol.
[122] A. Nanji,et al. Alcoholic Liver Injury in the Rat Is Associated with Reduced Expression of Peroxisome Proliferator-α (PPARα)-Regulated Genes and Is Ameliorated by PPARα Activation , 2004, Journal of Pharmacology and Experimental Therapeutics.
[123] M. Pagliassotti,et al. Hepatospecific effects of fructose on c-jun NH2-terminal kinase: implications for hepatic insulin resistance. , 2004, American journal of physiology. Endocrinology and metabolism.
[124] R. Townsend,et al. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. , 2004, The Journal of clinical endocrinology and metabolism.
[125] R. Rodrigo,et al. Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. , 2004, Clinical science.
[126] E. Gracely,et al. The Effects of Low-Carbohydrate versus Conventional Weight Loss Diets in Severely Obese Adults: One-Year Follow-up of a Randomized Trial , 2004, Annals of Internal Medicine.
[127] S. M. Robinson,et al. Triglycerides induce leptin resistance at the blood-brain barrier. , 2004, Diabetes.
[128] E. Ford,et al. Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment. , 2004, The American journal of clinical nutrition.
[129] K. Mak,et al. Model of nonalcoholic steatohepatitis. , 2004, The American journal of clinical nutrition.
[130] L. Hertz. Biochemistry, physiology and pharmacology , 2004 .
[131] Trends in intake of energy and macronutrients--United States, 1971-2000. , 2004, MMWR. Morbidity and mortality weekly report.
[132] A. Nanji,et al. Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation. , 2004, The Journal of pharmacology and experimental therapeutics.
[133] Rachel K. Johnson,et al. Children and adolescents' choices of foods and beverages high in added sugars are associated with intakes of key nutrients and food groups. , 2004, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[134] S. Shoelson,et al. Inflammation and the IKKβ/IκB/NF-κB axis in obesity- and diet-induced insulin resistance , 2003, International Journal of Obesity.
[135] R. Deutsch,et al. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. , 2003, The Journal of pediatrics.
[136] J. F. Morton,et al. Did fat intake in the United States really decline between 1989-1991 and 1994-1996? , 2003, Journal of the American Dietetic Association.
[137] M. Bennett,et al. Molecular and phenotypic heterogeneity in mitochondrial trifunctional protein deficiency due to β‐subunit mutations , 2003 .
[138] V. Preedy,et al. Nutritional intake of hazardous drinkers and dependent alcoholics in the UK , 2003, Addiction biology.
[139] E. Gracely,et al. A low-carbohydrate as compared with a low-fat diet in severe obesity. , 2003, The New England journal of medicine.
[140] G. Marchesini,et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.
[141] B. Levi,et al. Fructose and related phosphate derivatives impose DNA damage and apoptosis in L5178Y mouse lymphoma cells. , 2003, The Journal of nutritional biochemistry.
[142] Cicely D. Williams,et al. Kwashiorkor: a nutritional disease of children associated with a maize diet. 1935. , 2003, Bulletin of the World Health Organization.
[143] S. Shoelson,et al. Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. , 2003, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[144] J. Schwarz,et al. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. , 2003, The American journal of clinical nutrition.
[145] Michael Karin,et al. A central role for JNK in obesity and insulin resistance , 2002, Nature.
[146] N. Keim,et al. Fructose, weight gain, and the insulin resistance syndrome. , 2002, The American journal of clinical nutrition.
[147] A. Koteish,et al. Animal models of steatohepatitis. , 2002, Best practice & research. Clinical gastroenterology.
[148] A. Lonardo,et al. Apolipoprotein synthesis in nonalcoholic steatohepatitis , 2002, Hepatology.
[149] T. Osborne,et al. Role of Sterol Regulatory Element Binding Proteins in the Regulation of G&agr;i2 Expression in Cultured Atrial Cells , 2002, Circulation research.
[150] A. Häkkinen,et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. , 2002, The Journal of clinical endocrinology and metabolism.
[151] H. Maegawa,et al. Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha. , 2002, American journal of physiology. Endocrinology and metabolism.
[152] G. Pacini,et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association , 2002, Hepatology.
[153] I. G. Fantus,et al. Hepatic Very Low Density Lipoprotein-ApoB Overproduction Is Associated with Attenuated Hepatic Insulin Signaling and Overexpression of Protein-tyrosine Phosphatase 1B in a Fructose-fed Hamster Model of Insulin Resistance* , 2002, The Journal of Biological Chemistry.
[154] P L daLuz,et al. Alcohol and atherosclerosis. , 2001, Anais da Academia Brasileira de Ciencias.
[155] Steven L Gortmaker,et al. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis , 2001, The Lancet.
[156] V. Noé,et al. DAG accumulation from saturated fatty acids desensitizes insulin stimulation of glucose uptake in muscle cells. , 2001, American journal of physiology. Endocrinology and metabolism.
[157] A. Diehl,et al. Animal Models of Steatosis , 2001, Seminars in liver disease.
[158] M. Ueno,et al. A high fructose diet affects the early steps of insulin action in muscle and liver of rats. , 2000, The Journal of nutrition.
[159] M. Hellerstein,et al. Relationship between carbohydrate-induced hypertriglyceridemia and fatty acid synthesis in lean and obese subjects. , 2000, Journal of lipid research.
[160] L. Aggerbeck,et al. The role of the microsomal triglygeride transfer protein in abetalipoproteinemia. , 2000, Annual review of nutrition.
[161] G. Marchesini,et al. Association of nonalcoholic fatty liver disease with insulin resistance. , 1999, The American journal of medicine.
[162] M. Hellerstein,et al. De novo lipogenesis, lipid kinetics, and whole-body lipid balances in humans after acute alcohol consumption. , 1999, The American journal of clinical nutrition.
[163] Jay D. Horton,et al. Increased Levels of Nuclear SREBP-1c Associated with Fatty Livers in Two Mouse Models of Diabetes Mellitus* , 1999, The Journal of Biological Chemistry.
[164] B. Middleton,et al. The mechanism of inhibition of β-oxidation by aspirin metabolites in skin fibroblasts from Reye’s syndrome patients and controls , 1999 .
[165] L. DiPietro,et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study , 1999, Diabetologia.
[166] A. Burt,et al. Diagnosis and interpretation of steatosis and steatohepatitis. , 1998, Seminars in diagnostic pathology.
[167] C. Day,et al. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. , 1998, Journal of hepatology.
[168] Kenneth R Feingold,et al. Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines. , 1998, American journal of physiology. Endocrinology and metabolism.
[169] C. Day,et al. A disease of emerging identity and importance , 1998 .
[170] H. Sano,et al. Hydroxyl Radical Mediates Nϵ-(Carboxymethyl)lysine Formation from Amadori Product , 1997 .
[171] J. McGarry,et al. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. , 1997, European journal of biochemistry.
[172] H. Sano,et al. Hydroxyl radical mediates N epsilon-(carboxymethyl)lysine formation from Amadori product. , 1997, Biochemical and biophysical research communications.
[173] D. Chinkes,et al. Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man. , 1996, The Journal of clinical investigation.
[174] P. Raven,et al. Child, Adolescent and Family Refugee Mental Health: A Global Perspective , 1996 .
[175] S. Turner,et al. Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection. , 1995, The Journal of clinical investigation.
[176] D. Cahill,et al. Ethanol modulates apolipoprotein B mRNA editing in the rat. , 1995, Journal of lipid research.
[177] Jason Liggins. Fructose and the Maillard reaction , 1995 .
[178] C. R. Kahn,et al. Insulin Action, Diabetogenes, and the Cause of Type II Diabetes , 1994, Diabetes.
[179] W. Dills,et al. Protein fructosylation: fructose and the Maillard reaction. , 1993, The American journal of clinical nutrition.
[180] P. J. Jones,et al. Measurement of human lipogenesis using deuterium incorporation. , 1993, Journal of lipid research.
[181] G. Griffin,et al. Ultrasonographic assessment of the extent of hepatic steatosis in severe malnutrition. , 1992, Archives of disease in childhood.
[182] P. Pasquet,et al. Massive overfeeding and energy balance in men: the Guru Walla model. , 1992, The American journal of clinical nutrition.
[183] A. J. Furth,et al. Failure of common glycation assays to detect glycation by fructose. , 1992, Clinical chemistry.
[184] M. Hellerstein,et al. Measurement of de novo hepatic lipogenesis in humans using stable isotopes. , 1991, The Journal of clinical investigation.
[185] I. Wanless,et al. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors , 1990, Hepatology.
[186] M. Guzmán,et al. Alterations in the regulatory properties of hepatic fatty acid oxidation and carnitine palmitoyltransferase I activity after ethanol feeding and withdrawal. , 1990, Alcoholism, clinical and experimental research.
[187] A. Kuksis,et al. Impaired very low-density lipoprotein-triglyceride catabolism in acute and chronic fructose-fed rats. , 1989, The American journal of physiology.
[188] D. Godin,et al. Nutritional deficiency, starvation, and tissue antioxidant status. , 1988, Free radical biology & medicine.
[189] F. Schaffner,et al. Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.
[190] K. Maurer,et al. Third national health and nutrition examination survey , 1985 .
[191] H. Greene,et al. Steatohepatitis in obese children: a cause of chronic liver dysfunction. , 1983, The American journal of gastroenterology.
[192] P. Higgins,et al. Reaction of monosaccharides with proteins: possible evolutionary significance. , 1981, Science.
[193] S. Zeisel. Dietary choline: biochemistry, physiology, and pharmacology. , 1981, Annual review of nutrition.
[194] J. Ludwig,et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. , 1980, Mayo Clinic proceedings.
[195] F. Snyder,et al. Regulation of ether lipids and their precursors in relation to glycolysis in cultured neoplastic cells. , 1979, Biochimica et biophysica acta.
[196] I. H. Glass,et al. Reye's syndrome: massive fatty metamorphosis of the liver with acute encephalopathy. , 1968, Canadian Medical Association journal.
[197] Cicely D. Williams. KWASHIORKOR: A NUTRITIONAL DISEASE OF CHILDREN ASSOCIATED WITH A MAIZE DIET , 1935 .